Matthew T. Wiley

Chief Commercial Officer, Definium Therapeutics, Inc.

Bought, 12 months

$0.0M

Sold, 12 months

$0.2M

Companies

Latest trade

Sep 25, 2026

Companies

Definium Therapeutics, Inc.Chief Commercial Officer −$0.2M

Trades

DFTX Sold 3,097 shares at $36.57 · planned $0.1M Sep 25

DFTX Sold 2,867 shares at $45.03 · planned $0.1M Jun 25

Open-market trades from SEC Form 4 only: no grants, option exercises or gifts. People are matched by the name on their filings, so two people with the same name share this page. For information only — not investment advice.